Media
Press releases
-
The extraordinary general meeting of AlzeCure Pharma AB approved the decision on the new issue of shares
April 25, 2024
-
AlzeCure publishes its interim report for January – March 2024
April 25, 2024
-
Eli Lilly’s and AstraZeneca’s former head of research Dr. Jan Lundberg invests in AlzeCure and is proposed for election to its board
April 10, 2024